Herpes Virus Infections During Treatment With Etanercept in Juvenile Idiopathic Arthritis

被引：6
|
作者：
Nicolai, R. [1 ]
Cortis, E. [4 ]
Rava, L. [3 ]
Bracaglia, C. [1 ]
Pardeo, M. [1 ]
Insalaco, A. [1 ]
Buonuomo, P. S. [2 ]
Tozzi, A. E. [3 ]
De Benedetti, F. [1 ]
机构：
[1] Bambino Gesu Pediat Hosp, Dept Pediat Med, IRCCS, Div Rheumatol, Piazza St Onofrio 4, I-00165 Rome, Italy
[2] Bambino Gesu Pediat Hosp, Dept Pediat Med, Ist Ricovero & Cura Carattere Sci, Div Rare Dis, Rome, Italy
[3] Bambino Gesu Pediat Hosp, Div Epidemiol, Ist Ricovero & Cura Carattere Sci, Rome, Italy
[4] Osped Santa Maria Stella, Div Pediat, Orvieto, Italy
来源：
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2016年 / 5卷 / 01期
关键词：
etanercept; herpes simplex virus; juvenile idiopathic arthritis; varicella zoster virus; RHEUMATOID-ARTHRITIS; SAFETY; EFFICACY; REGISTRY; CHILDREN; THERAPY;
D O I：
10.1093/jpids/piu078
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Incidence rates for varicella and herpes zoster were similar in patients with juvenile idiopathic arthritis receiving etanercept/methotrexate (n = 85, 184.9 patient-years [PY]) or methotrexate alone (n = 71, 199.4 PY); no complicated varicella or herpes zoster cases were reported; herpes labialis incidence was higher in patients receiving etanercept/methotrexate versus methotrexate alone (0.38 vs 0.24 PY).
引用
收藏
页码：76 / 79
页数：4
相关论文
共 50 条
  • [31] Etanercept in systemic juvenile idiopathic arthritis
    Russo, RAG
    Katsicas, MM
    Zelazko, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (05) : 723 - 726
  • [32] Comparative efficacy and safety of etanercept and adalimumab in the treatment of polyarticular juvenile idiopathic arthritis
    Ge, Lanlan
    Gao, Yu
    Chen, Xin
    Guo, Jingxiao
    Zhang, Dongfeng
    Yang, Yanjun
    BMC PEDIATRICS, 2025, 25 (01)
  • [33] Guidelines on the use of etanercept for juvenile idiopathic arthritis in Japan
    Yokota, Shumpei
    Mori, Masaaki
    Imagawa, Tomoyuki
    Murata, Takuji
    Tomiita, Minako
    Itoh, Yasuhiko
    Fujikawa, Satoshi
    Takei, Syuji
    MODERN RHEUMATOLOGY, 2010, 20 (02) : 107 - 113
  • [34] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
    Katsicas, Maria M.
    Russo, Ricardo A. G.
    CLINICAL RHEUMATOLOGY, 2009, 28 (08) : 985 - 988
  • [35] Modern treatment of juvenile idiopathic arthritis
    Horneff, G.
    MONATSSCHRIFT KINDERHEILKUNDE, 2014, 162 (08) : 693 - 700
  • [36] Juvenile Idiopathic Arthritis Treatment Updates
    Onel, Karen
    Rumsey, Dax G.
    Shenoi, Susan
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2021, 47 (04) : 545 - 563
  • [37] Development of germinoma during the treatment of systemic-onset juvenile idiopathic arthritis with infliximab
    Takezaki, Shunichiro
    Okura, Yuka
    Ichikawa, Mizuho
    Suzuki, Daisuke
    Ohshima, Junjiro
    Kaneda, Makoto
    Cho, Yuko
    Yamada, Masafumi
    Kawamura, Nobuaki
    Iguchi, Akihiro
    Kobayashi, Ichiro
    Ariga, Tadashi
    MODERN RHEUMATOLOGY, 2012, 22 (04) : 621 - 624
  • [38] Modern treatment of juvenile idiopathic arthritis
    Horneff, G.
    MONATSSCHRIFT KINDERHEILKUNDE, 2014, 162 (08) : 693 - 700
  • [39] Safety and efficacy of etanercept and adalimumab in children aged 2 to 4 years with juvenile idiopathic arthritis
    Windschall, D.
    Horneff, G.
    CLINICAL RHEUMATOLOGY, 2016, 35 (12) : 2925 - 2931
  • [40] Crohn's disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature
    Wiegering, V.
    Morbach, H.
    Dick, A.
    Girschick, H. J.
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (06) : 801 - 804
12345